Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)

NCT02348918 is registered in ClinicalTrials.gov with Allegro Ophthalmics, LLC as lead sponsor.

NCT NCT02348918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02348918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Lead sponsor
Allegro Ophthalmics, LLC
Phase
Phase 2
Overall status
Completed
Start date
October 13, 2014
Completion date
June 13, 2017
Enrollment
218 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema